Literature DB >> 4626496

An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.

W G Jennings.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4626496     DOI： 10.1111/j.1532-5415.1972.tb01645.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  4 in total

Review 1.  Periodic health examination, 1991 update: 1. Screening for cognitive impairment in the elderly. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-02-15       Impact factor: 8.262

2.  The effect of hydergine on the transit time of cerebral circulation in diffuse cerebral insufficiency.

Authors:  B Mongeau
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 3.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  J C Soares; S Gershon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

4.  Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry.

Authors:  B Saletu; J Grünberger; L Linzmayer; P Anderer
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.